Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin

Documenti analoghi

• MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia
  di: Whigham, Carole-Anne, et al.
  Pubblicazione: (2020)
• Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
  di: Kaitu’u-Lino, Tu’uhevaha J., et al.
  Pubblicazione: (2018)
• Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
  di: Tong, Stephen, et al.
  Pubblicazione: (2020)
• Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia
  di: Hannan, Natalie J., et al.
  Pubblicazione: (2018)
• Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta
  di: Brownfoot, Fiona C., et al.
  Pubblicazione: (2016)